drugset / Trial / NCT02005523

Study of RNS60 on Pain and Function After Hip Labral Repair

NCT02005523

Phase 2 Withdrawn Revalesio Corporation
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to see if use of RNS60 during hip labral repair surgery decreases pain and improves functional capacity post-operation.

Timeline

Start
Primary completion
2014-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject RNS60 Other / unclassified

Indications

No indication recorded.